Stay updated on Amivantamab SC in Advanced Solid Malignancies Clinical Trial
Sign up to get notified when there's something new on the Amivantamab SC in Advanced Solid Malignancies Clinical Trial page.

Latest updates to the Amivantamab SC in Advanced Solid Malignancies Clinical Trial page
- Check7 days agoChange DetectedThe page changes from a 403 Forbidden response to the ClinicalTrials.gov record for the amivantamab study, displaying its study details, eligibility criteria, locations, and outcomes.SummaryDifference49%

- Check14 days agoChange DetectedThe ClinicalTrials.gov site revision label changed from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check21 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0 on the 403 error page.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record, indicating access to the content is blocked. This replaces visible study information with an error state.SummaryDifference18%

Stay in the know with updates to Amivantamab SC in Advanced Solid Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab SC in Advanced Solid Malignancies Clinical Trial page.